Pain studies face unique challenges. For one, pain severity can only be truly assessed by the patients themselves. The controlled substances that are often used as experimental treatments in these studies bring stricter drug accountability requirements. Pain patients also face debilitating symptoms that can make participation in studies difficult. That’s where Signant Health’s solutions can help.
Pain is unique in that it can also be studied across many different indications, including:
- Migraine/Headache
- Osteoarthritis
- Diabetic Neuropathy
- Postoperative Pain
- Postherpetic Neuralgia
- Acute/Chronic Low Back Pain
- Trigeminal Neuralgia
- Cancer - Fibromyalgia
- Complex Regional Pain Syndrome
